Investigation: Menlo Therapeutics (“MNLO”) I.P.O. Losses
The Sonn Law Group is Investigating Menlo Therapeutics I.P.O. Losses Miami, FL - May 28, 2018 Sonn Law Group is investigating Menlo Therapeutics (“MNLO”) regarding its IPO, and subsequent stock sales to investors through April 9, 2018. In January 2018, Menlo Therapeutics went public issuing over 8,000,000 shares of common stock at a public offering [...]

























